Cargando…

Management of acute stroke in patients taking novel oral anticoagulants

Each year, 1·0–2·0% of individuals with atrial fibrillation and 0·1–0·2% of those with venous thromboembolism who are receiving one of the novel oral anticoagulants (dabigatran, rivaroxaban, or apixaban) can be expected to experience an acute ischemic stroke. Additionally, 0·2–0·5% of individuals wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hankey, Graeme J, Norrving, Bo, Hacke, Werner, Steiner, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149783/ https://www.ncbi.nlm.nih.gov/pubmed/24891030 http://dx.doi.org/10.1111/ijs.12295

Ejemplares similares

Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran
por: Curto, Adrian, et al.
Publicado: (2017)

Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial
por: Åsberg, Signild, et al.
Publicado: (2017)

Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Reversal Treatment in Oral Anticoagulant-Related Intracerebral Hemorrhage—An Observational Study Based on the Swedish Stroke Register
por: Apostolaki-Hansson, Trine, et al.
Publicado: (2020)

Anticoagulation for the Acute Management of Ischemic Stroke
por: Robinson, Austin A., et al.
Publicado: (2014)

Association of Alternative Anticoagulation Strategies and Outcomes in Patients With Ischemic Stroke While Taking a Direct Oral Anticoagulant
por: Ip, Yiu Ming Bonaventure, et al.
Publicado: (2023)

Patient factors associated with receiving reversal therapy in oral anticoagulant‐related intracerebral hemorrhage
por: Apostolaki‐Hansson, Trine, et al.
Publicado: (2022)

Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study
por: Sjögren, Vilhelm, et al.
Publicado: (2017)

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation
por: Friberg, Leif, et al.
Publicado: (2019)

Early Versus Delayed Non–Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study
por: Oldgren, Jonas, et al.
Publicado: (2022)

Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation
por: Camm, A. John, et al.
Publicado: (2015)

B vitamins for stroke prevention
por: Hankey, Graeme J
Publicado: (2018)

Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
por: Steiner, Thorsten, et al.
Publicado: (2018)

Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications
por: Costantinides, Fulvia, et al.
Publicado: (2016)

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
por: Luger, Sebastian, et al.
Publicado: (2015)

To Treat or Not to Treat: Low‐Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours
por: Kam, Wayneho, et al.
Publicado: (2022)

Management of the patient with an acute coronary syndrome using oral anticoagulation
por: Vos, G.J.A., et al.
Publicado: (2015)

Management of Oral Anticoagulation and Antiplatelet Therapy in Post-Myocardial Infarction Patients with Acute Ischemic Stroke with and without Atrial Fibrillation
por: Pezzella, Francesca Romana, et al.
Publicado: (2022)

Multicenter experience with photoselective vaporization of the prostate on men taking novel oral anticoagulants
por: Sachs, Brooke, et al.
Publicado: (2020)

Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient
por: Yates, Scott W
Publicado: (2013)

Is it necessary to alter anticoagulation therapy for tooth extraction in patients taking direct oral anticoagulants?
por: Caliskan, Mehmet, et al.
Publicado: (2017)

Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants
por: Purrucker, Jan C., et al.
Publicado: (2017)

Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
por: Cheung, Ka-Shing, et al.
Publicado: (2017)

Knowledge and medication adherence of oral anticoagulant-taking patients in Vietnam
por: Tran, Minh-Hoang, et al.
Publicado: (2023)

A Systematic Review on Mobile Health Applications’ Education Program for Patients Taking Oral Anticoagulants
por: Jang, Insil
Publicado: (2021)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Patients Taking Direct Oral Anticoagulants (DOAC) Undergoing Oral Surgery: A Review of the Literature and a Proposal of a Peri-Operative Management Protocol
por: Lupi, Saturnino Marco, et al.
Publicado: (2020)

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022)

A Study of the Management of Patients Taking Novel Oral Antiplatelet or Direct Oral Anticoagulant Medication Undergoing Dental Surgery in a Rural Setting
por: Johnston, Steven
Publicado: (2015)

Perioperative management of patients on direct oral anticoagulants
por: Dubois, Virginie, et al.
Publicado: (2017)

Global assays and the management of oral anticoagulation
por: Brinkman, Herm Jan M
Publicado: (2015)

What Is the Best Mix of Population‐Wide and High‐Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
por: Feigin, Valery L., et al.
Publicado: (2020)

Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants
por: Seiffge, David J, et al.
Publicado: (2021)

Trends in direct oral anticoagulant use in patients presenting with acute stroke
por: Teow, Kang H., et al.
Publicado: (2022)

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
por: Chang, Po-Yin, et al.
Publicado: (2021)

Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants
por: Morimoto, Yoshinari, et al.
Publicado: (2016)

Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
por: Kim, Gwang-Un, et al.
Publicado: (2021)

Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
por: Morais, João, et al.
Publicado: (2016)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
por: Caturano, Alfredo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iobunv50unf83k27kah7pkae80